TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM NEW
Total 13F shares
2,645,326
Share change
-1,043,643
Total reported value
$14,949,000
Price per share
$5.65
Number of holders
29
Value change
-$17,101,352
Number of buys
20
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q4 2016

As of 31 Dec 2016, TRILLIUM THERAPEUTICS INC - COM NEW was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,645,326 shares. The largest 10 holders included JANUS CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, venBio Select Advisor LLC, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, Candriam Luxembourg S.C.A., Opaleye Management Inc., Sectoral Asset Management Inc, New Leaf Venture Partners, L.L.C., and PUTNAM INVESTMENTS LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.